$3.05
0.144.81%
At Close: -
$2.88
-0.17-5.57%
After Hours: Aug 23, 8:57 AM EDT
15 minutes delayed
Comments
Loading...
Sunshine Biopharma (NASDAQ:SBFM) Stock, Earnings Estimates, EPS, And Revenue
Sunshine Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 16
EPS
$-9.940
Quarterly Revenue
$9.3M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$30.5M
Analyze the earnings history of Sunshine Biopharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Sunshine Biopharma (SBFM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-16 | $-9.94 | $-0.37 | -2586.5 % |
| Mar 2024 | 2024-05-20 | $-2.00 | $-8.00 | 75.0 % |
| Dec 2023 | 2024-03-28 | $-6.00 | $-3.00 | -100.0 % |
| Sep 2023 | 2023-11-13 | $-4.00 | $-6.00 | 33.3 % |
Sunshine Biopharma (SBFM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-16 | $9.30M | $9.00M | 3.37 % |
| Mar 2024 | 2024-05-20 | $7.54M | $7.00M | 7.73 % |
| Dec 2023 | 2024-03-28 | $7.68M | $6.10M | 25.9 % |
| Sep 2023 | 2023-11-13 | $5.60M | $6.00M | -6.70 % |
FAQ
When is Sunshine Biopharma (NASDAQ:SBFM) reporting earnings?
Sunshine Biopharma (SBFM) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 16, 2024 for Q2.
What were the latest earnings per share (EPS) for Sunshine Biopharma (NASDAQ:SBFM)?
The Actual EPS was $-9.94, which missed the estimate of $-0.37.
What were Sunshine Biopharma’s (NASDAQ:SBFM) revenues?
The Actual Revenue was $9.3M, which beat the estimate of $9M.
Browse earnings estimates, EPS, and revenue on all stocks.